Drug intelligence / Profile preview

technetium Tc-99m sodium pertechnetate

Development stage
Approved
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous, Intravesical, Ophthalmic
01

Overview

Technetium Tc‑99m sodium pertechnetate is a radiopharmaceutical diagnostic agent used in nuclear medicine for imaging various organs and tissues. It consists of the metastable isotope technetium‑99m complexed as the pertechnetate anion (TcO₄⁻), which mimics iodide in biological systems. After intravenous or local administration, it distributes primarily to the thyroid gland, salivary glands, gastric mucosa, choroid plexus, and urinary bladder. Its mechanism relies on gamma-ray emission from decay of technetium‑99m (half-life ~6 hours), enabling detection by gamma cameras during single photon emission computed tomography (SPECT) or planar scintigraphy. It is widely used for thyroid imaging and function studies, salivary gland imaging, brain perfusion studies (including assessment of brain death), urinary bladder imaging for vesicoureteral reflux detection, and nasolacrimal drainage system evaluation. The drug is supplied via generators that elute the short-lived isotope from molybdenum‑99 parent nuclide shortly before use[1][2][3][4][5][6].

Brand names
DrytecTechneLitePertscan-99mPertscan99mPertscan 99m
Other names
technetium Tc 99m sodium pertechnetatesodium pertechnetate Tc 99m injectionsodium pertechnetate (Na[99m]TcO4)technetium Tc 99m O(4)technetium Tc 99m pertechnetate
02

Targets

NIS (Human sodium iodide symporter)

Beyond the preview

Go deeper on technetium Tc-99m sodium pertechnetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on technetium Tc-99m sodium pertechnetate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call